Citius Oncology Inc (CTOR)
1.026
-0.11
(-10.02%)
USD |
NASDAQ |
Nov 04, 16:00
1.01
-0.02
(-1.54%)
After-Hours: 20:00
Citius Oncology Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Citius Pharmaceuticals Inc | 45.11M |
| NovaBay Pharmaceuticals Inc | 3.645M |
| Palatin Technologies Inc | 13.74M |
| iBio Inc | 9.837M |
| Theriva Biologics Inc | -12.61M |